NCT04507503 2026-03-10Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene RearrangementsTaiho Oncology, Inc.Approved for marketing
NCT06877676 2026-02-13Pre-Approval Expanded Access Study for TAR-200 Treating Physician UseJanssen Research & Development, LLCApproved for marketing